| Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer New England Journal of Medicine 380, 617-628, 2019 | 2134 | 2019 |
| Planning cancer control in Latin America and the Caribbean PE Goss, BL Lee, T Badovinac-Crnjevic, K Strasser-Weippl, ... The lancet oncology 14 (5), 391-436, 2013 | 625 | 2013 |
| Challenges to effective cancer control in China, India, and Russia PE Goss, K Strasser-Weippl, BL Lee-Bychkovsky, L Fan, J Li, ... The lancet oncology 15 (5), 489-538, 2014 | 557 | 2014 |
| Progress and remaining challenges for cancer control in Latin America and the Caribbean K Strasser-Weippl, Y Chavarri-Guerra, C Villarreal-Garza, BL Bychkovsky, ... The lancet oncology 16 (14), 1405-1438, 2015 | 199 | 2015 |
| Breast cancer in Mexico: a growing challenge to health and the health system Y Chávarri-Guerra, C Villarreal-Garza, PER Liedke, F Knaul, A Mohar, ... The Lancet Oncology 13 (8), e335-e343, 2012 | 188 | 2012 |
| Breast cancer in young women in Latin America: an unmet, growing burden C Villarreal‐Garza, C Aguila, MC Magallanes‐Hoyos, A Mohar, ... The oncologist 18 (S2), 26-34, 2013 | 184 | 2013 |
| Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial PE Goss, IE Smith, J O'Shaughnessy, B Ejlertsen, M Kaufmann, F Boyle, ... The Lancet Oncology 14 (1), 88-96, 2013 | 179 | 2013 |
| Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole PE Goss, JN Ingle, S Martino, NJ Robert, HB Muss, RB Livingston, ... Annals of oncology 24 (2), 355-361, 2013 | 121 | 2013 |
| Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort study PER Liedke, DM Finkelstein, J Szymonifka, CH Barrios, ... Cancer Epidemiology, Biomarkers & Prevention 23 (1), 126-133, 2014 | 119 | 2014 |
| Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) T Bachelot, E Ciruelos, A Schneeweiss, F Puglisi, T Peretz-Yablonski, ... Annals of Oncology 30 (5), 766-773, 2019 | 107 | 2019 |
| Global geriatric oncology: achievements and challenges E Soto-Perez-de-Celis, NA de Glas, T Hsu, R Kanesvaran, C Steer, ... Journal of Geriatric Oncology 8 (5), 374-386, 2017 | 92 | 2017 |
| Providing supportive and palliative care using telemedicine for patients with advanced cancer during the COVID‐19 pandemic in Mexico Y Chávarri‐Guerra, WA Ramos‐López, A Covarrubias‐Gómez, ... The oncologist 26 (3), e512-e515, 2021 | 66 | 2021 |
| End-of-life care in Latin America E Soto-Perez-de-Celis, Y Chavarri-Guerra, T Pastrana, R Ruiz-Mendoza, ... Journal of Global Oncology 3 (3), 261-270, 2017 | 66 | 2017 |
| Tumor-associated neutrophils in breast cancer subtypes E Soto-Perez-de-Celis, Y Chavarri-Guerra, E Leon-Rodriguez, ... Asian Pacific journal of cancer prevention: APJCP 18 (10), 2689, 2017 | 53 | 2017 |
| Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward CH Barrios, G Werutsky, A Mohar, AS Ferrigno, BG Müller, BL Bychkovsky, ... The Lancet Oncology 22 (11), e474-e487, 2021 | 50 | 2021 |
| National and regional breast cancer incidence and mortality trends in Mexico 2001–2011: Analysis of a population-based database E Soto-Perez-de-Celis, Y Chavarri-Guerra Cancer Epidemiology 41, 24-33, 2016 | 50 | 2016 |
| Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a … D Miles, E Ciruelos, A Schneeweiss, F Puglisi, T Peretz-Yablonski, ... Annals of Oncology 32 (10), 1245-1255, 2021 | 45 | 2021 |
| Loss of fingerprints Y Chavarri-Guerra, E Soto-Perez-de-Celis New England Journal of Medicine 372 (16), e22, 2015 | 42 | 2015 |
| Expressed gene fusions as frequent drivers of poor outcomes in hormone receptor–positive breast cancer KJ Matissek, ML Onozato, S Sun, Z Zheng, A Schultz, J Lee, K Patel, ... Cancer discovery 8 (3), 336-353, 2018 | 41 | 2018 |
| Genetic cancer risk assessment for breast cancer in Latin America Y Chavarri-Guerra, KR Blazer, JN Weitzel Revista de investigación clinica 69 (2), 94-102, 2017 | 41 | 2017 |
